MAGPIE: Simplifying access and execution of computational models in the life sciences.

by Christoph Baldow, Sebastian Salentin, Michael Schroeder, Ingo Roeder, Ingmar Glauche
Published 2017-12-01

Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor

by Sarah Naomi Bolz, Sebastian Salentin, Gary Jennings, V. Joachim Haupt, Jared Sterneckert, Michael Schroeder
Published 2021-01-01

Backbone Brackets and Arginine Tweezers delineate Class I and Class II aminoacyl tRNA synthetases.

by Florian Kaiser, Sebastian Bittrich, Sebastian Salentin, Christoph Leberecht, V Joachim Haupt, Sarah Krautwurst, Michael Schroeder, Dirk Labudde
Published 2018-04-01

Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor.

by Melissa F Adasme, Daniele Parisi, Kristien Van Belle, Sebastian Salentin, V Joachim Haupt, Gary S Jennings, Jörg-Christian Heinrich, Jean Herman, Ben Sprangers, Thierry Louat, Yves Moreau, Michael Schroeder
Published 2020-01-01

Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling

by Alfredo Juárez-Saldivar, Michael Schroeder, Sebastian Salentin, V. Joachim Haupt, Emma Saavedra, Citlali Vázquez, Francisco Reyes-Espinosa, Verónica Herrera-Mayorga, Juan Carlos Villalobos-Rocha, Carlos A. García-Pérez, Nuria E. Campillo, Gildardo Rivera
Published 2020-06-01

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning

by Melissa F. Adasme, Sarah Naomi Bolz, Lauren Adelmann, Sebastian Salentin, V. Joachim Haupt, Adriana Moreno-Rodríguez, Benjamín Nogueda-Torres, Verónica Castillo-Campos, Lilián Yepez-Mulia, José A. De Fuentes-Vicente, Gildardo Rivera, Michael Schroeder
Published 2020-11-01